Vaccinex Historical Balance Sheet

VCNX Stock

USD 3.69 0.13 3.65%

Trend analysis of Vaccinex balance sheet accounts such as Total Assets of 6.8 M, Short Long Term Debt Total of 234.7 K, Other Current Liabilities of 1.9 M or Total Current Liabilities of 4.6 M provides information on Vaccinex's total assets, liabilities, and equity, which is the actual value of Vaccinex to its prevalent stockholders. By breaking down trends over time using Vaccinex balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Vaccinex latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vaccinex is a good buy for the upcoming year.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaccinex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Vaccinex Stock please use our How to Invest in Vaccinex guide.

About Vaccinex Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Vaccinex at a specified time, usually calculated after every quarter, six months, or one year. Vaccinex Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Vaccinex and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Vaccinex currently owns. An asset can also be divided into two categories, current and non-current.

Vaccinex Balance Sheet Chart

At this time, Vaccinex's Common Stock is fairly stable compared to the past year. Property Plant Equipment is likely to rise to about 451.1 K in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 234.7 K in 2024.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Property Plant And Equipment Net Total Liab

Add Fundamental

Total Assets

Total assets refers to the total amount of Vaccinex assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Vaccinex books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Vaccinex balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Vaccinex are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most accounts from Vaccinex's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Vaccinex current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaccinex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Vaccinex Stock please use our How to Invest in Vaccinex guide.At this time, Vaccinex's Common Stock is fairly stable compared to the past year. Property Plant Equipment is likely to rise to about 451.1 K in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 234.7 K in 2024.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	390K	485K	247K	234.7K
Total Assets	9.8M	8.0M	3.6M	6.8M

Short Long Term Debt Total Total Assets

Vaccinex balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Short Long Term Debt
Total Assets		0.63	0.35	0.35	-0.17	-0.6	0.57	-0.36	-0.65	-0.32	-0.13	0.66	-0.36	-0.29	-0.04	0.98	0.22	0.02	0.58	-0.48	0.58	0.68	0.49	0.17	0.1	0.6
Short Long Term Debt Total	0.63		0.61	0.76	-0.84	-0.44	0.26	-0.12	-0.18	-0.03	0.6	0.48	-0.12	-0.32	0.33	0.65	0.29	-0.28	0.45	0.23	0.44	0.14	0.21	0.64	-0.43	1.0
Other Current Liab	0.35	0.61		0.41	-0.49	-0.23	0.16	-0.06	0.09	0.04	0.48	-0.21	-0.06	0.09	0.16	0.33	0.65	0.02	0.26	0.1	0.27	-0.13	0.08	0.28	-0.31	0.62
Total Current Liabilities	0.35	0.76	0.41		-0.81	-0.28	0.19	-0.28	0.22	-0.13	0.7	0.43	-0.28	-0.26	0.17	0.36	0.22	-0.02	0.29	0.06	0.35	0.1	0.18	0.93	-0.35	0.76
Total Stockholder Equity	-0.17	-0.84	-0.49	-0.81		0.28	0.02	0.06	-0.27	-0.07	-0.78	-0.23	0.06	0.23	-0.51	-0.19	-0.26	0.23	-0.28	-0.56	-0.18	0.16	0.03	-0.82	0.54	-0.85
Other Liab	-0.6	-0.44	-0.23	-0.28	0.28		-0.81	0.85	0.61	0.79	0.29	-0.62	0.85	0.78	0.15	-0.54	-0.54	-0.51	-0.99	0.3	-0.87	-0.75	-0.85	-0.06	-0.53	-0.41
Net Tangible Assets	0.57	0.26	0.16	0.19	0.02	-0.81		-0.86	-0.68	-0.92	-0.35	0.51	-0.86	-0.82	-0.67	0.48	0.62	0.69	0.79	-0.65	0.94	0.77	0.97	-0.14	0.75	0.21
Property Plant And Equipment Net	-0.36	-0.12	-0.06	-0.28	0.06	0.85	-0.86		0.42	0.94	0.37	-0.49	1.0	0.76	0.49	-0.27	-0.56	-0.8	-0.84	0.56	-0.85	-0.77	-0.91	-0.06	-0.75	-0.08
Net Debt	-0.65	-0.18	0.09	0.22	-0.27	0.61	-0.68	0.42		0.49	0.59	-0.66	0.42	0.58	0.35	-0.66	-0.04	-0.1	-0.61	0.46	-0.66	-0.78	-0.67	0.45	-0.52	-0.14
Retained Earnings	-0.32	-0.03	0.04	-0.13	-0.07	0.79	-0.92	0.94	0.49		0.44	-0.4	0.94	0.82	0.66	-0.2	-0.61	-0.86	-0.76	0.61	-0.84	-0.72	-0.94	0.14	-0.86	0.02
Accounts Payable	-0.13	0.6	0.48	0.7	-0.78	0.29	-0.35	0.37	0.59	0.44		-0.16	0.37	0.16	0.38	-0.08	0.07	-0.42	-0.27	0.56	-0.17	-0.6	-0.38	0.74	-0.77	0.63
Cash	0.66	0.48	-0.21	0.43	-0.23	-0.62	0.51	-0.49	-0.66	-0.4	-0.16		-0.49	-0.62	-0.03	0.72	-0.2	-0.05	0.62	-0.29	0.6	0.77	0.56	0.3	0.19	0.45
Non Current Assets Total	-0.36	-0.12	-0.06	-0.28	0.06	0.85	-0.86	1.0	0.42	0.94	0.37	-0.49		0.76	0.49	-0.27	-0.56	-0.8	-0.84	0.56	-0.85	-0.77	-0.91	-0.06	-0.75	-0.08
Non Currrent Assets Other	-0.29	-0.32	0.09	-0.26	0.23	0.78	-0.82	0.76	0.58	0.82	0.16	-0.62	0.76		0.45	-0.25	-0.38	-0.47	-0.76	0.22	-0.86	-0.62	-0.87	-0.01	-0.59	-0.28
Long Term Debt	-0.04	0.33	0.16	0.17	-0.51	0.15	-0.67	0.49	0.35	0.66	0.38	-0.03	0.49	0.45		0.04	-0.35	-0.67	-0.14	0.75	-0.51	-0.38	-0.64	0.43	-0.76	0.38
Cash And Short Term Investments	0.98	0.65	0.33	0.36	-0.19	-0.54	0.48	-0.27	-0.66	-0.2	-0.08	0.72	-0.27	-0.25	0.04		0.06	-0.14	0.54	-0.41	0.53	0.64	0.42	0.2	-0.01	0.63
Net Receivables	0.22	0.29	0.65	0.22	-0.26	-0.54	0.62	-0.56	-0.04	-0.61	0.07	-0.2	-0.56	-0.38	-0.35	0.06		0.7	0.51	-0.21	0.56	0.16	0.54	0.0	0.38	0.27
Common Stock Shares Outstanding	0.02	-0.28	0.02	-0.02	0.23	-0.51	0.69	-0.8	-0.1	-0.86	-0.42	-0.05	-0.8	-0.47	-0.67	-0.14	0.7		0.47	-0.6	0.53	0.43	0.68	-0.21	0.84	-0.31
Long Term Debt Total	0.58	0.45	0.26	0.29	-0.28	-0.99	0.79	-0.84	-0.61	-0.76	-0.27	0.62	-0.84	-0.76	-0.14	0.54	0.51	0.47		-0.28	0.88	0.73	0.84	0.07	0.5	0.41
Non Current Liabilities Total	-0.48	0.23	0.1	0.06	-0.56	0.3	-0.65	0.56	0.46	0.61	0.56	-0.29	0.56	0.22	0.75	-0.41	-0.21	-0.6	-0.28		-0.48	-0.67	-0.61	0.27	-0.69	0.27
Capital Surpluse	0.58	0.44	0.27	0.35	-0.18	-0.87	0.94	-0.85	-0.66	-0.84	-0.17	0.6	-0.85	-0.86	-0.51	0.53	0.56	0.53	0.88	-0.48		0.72	0.96	0.02	0.58	0.39
Other Current Assets	0.68	0.14	-0.13	0.1	0.16	-0.75	0.77	-0.77	-0.78	-0.72	-0.6	0.77	-0.77	-0.62	-0.38	0.64	0.16	0.43	0.73	-0.67	0.72		0.78	-0.1	0.65	0.1
Other Stockholder Equity	0.49	0.21	0.08	0.18	0.03	-0.85	0.97	-0.91	-0.67	-0.94	-0.38	0.56	-0.91	-0.87	-0.64	0.42	0.54	0.68	0.84	-0.61	0.96	0.78		-0.13	0.77	0.15
Total Liab	0.17	0.64	0.28	0.93	-0.82	-0.06	-0.14	-0.06	0.45	0.14	0.74	0.3	-0.06	-0.01	0.43	0.2	0.0	-0.21	0.07	0.27	0.02	-0.1	-0.13		-0.55	0.66
Property Plant And Equipment Gross	0.1	-0.43	-0.31	-0.35	0.54	-0.53	0.75	-0.75	-0.52	-0.86	-0.77	0.19	-0.75	-0.59	-0.76	-0.01	0.38	0.84	0.5	-0.69	0.58	0.65	0.77	-0.55		-0.48
Short Long Term Debt	0.6	1.0	0.62	0.76	-0.85	-0.41	0.21	-0.08	-0.14	0.02	0.63	0.45	-0.08	-0.28	0.38	0.63	0.27	-0.31	0.41	0.27	0.39	0.1	0.15	0.66	-0.48

Click cells to compare fundamentals

Vaccinex Account Relationship Matchups

Vaccinex balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	4.6M	11.7M	9.8M	8.0M	3.6M	6.8M
Other Current Liab	3.7M	1.9M	980K	617K	3.4M	1.9M
Total Current Liabilities	6.9M	13.2M	2.3M	2.5M	5.9M	4.6M
Total Stockholder Equity	(26.2M)	(26.6M)	7.4M	5.2M	(2.3M)	(2.4M)
Net Tangible Assets	(8.6M)	(26.2M)	(26.6M)	7.4M	8.5M	8.9M
Property Plant And Equipment Net	594K	416K	438K	499K	282K	416.4K
Net Debt	(2.8M)	(1.4M)	(8.2M)	(5.9M)	(1.3M)	(1.4M)
Retained Earnings	(248.6M)	(277.5M)	(299.9M)	(319.7M)	(339.9M)	(356.9M)
Accounts Payable	3.2M	3.2M	1.1M	1.5M	2.0M	1.8M
Cash	2.8M	10.6M	8.6M	6.4M	1.5M	1.5M
Non Current Assets Total	594K	416K	438K	499K	282K	416.4K
Non Currrent Assets Other	(594K)	(416K)	(438K)	(499K)	(1.0)	(1.05)
Cash And Short Term Investments	2.8M	10.6M	8.6M	6.4M	1.5M	1.5M
Net Receivables	898K	157K	0.0	175K	961K	1.0M
Common Stock Shares Outstanding	61.3K	89.5K	137.4K	202.1K	463.7K	486.8K
Liabilities And Stockholders Equity	4.6M	11.7M	9.8M	8.0M	3.6M	6.8M
Non Current Liabilities Total	3.7M	1.1M	175K	247K	26K	24.7K
Other Current Assets	336K	1.1M	1.6M	912K	853K	946.6K
Other Stockholder Equity	222.4M	250.9M	307.3M	324.9M	337.6M	244.4M
Total Liab	6.9M	14.3M	2.4M	2.8M	5.9M	5.3M
Property Plant And Equipment Gross	594K	416K	7.5M	7.8M	7.4M	7.7M
Total Current Assets	4.0M	11.3M	9.4M	7.5M	3.3M	6.4M
Property Plant Equipment	604K	594K	416K	438K	394.2K	451.1K
Net Invested Capital	(26.2M)	(17.4M)	7.7M	5.4M	(2.2M)	(2.3M)
Net Working Capital	(2.9M)	(1.9M)	7.1M	4.9M	(2.6M)	(2.4M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Vaccinex Stock Analysis

When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Vaccinex Historical Balance Sheet

About Vaccinex Balance Sheet Analysis

Vaccinex Balance Sheet Chart

Total Assets

Total Current Liabilities

Property Plant And Equipment Net

Total Liab

Vaccinex balance sheet Correlations

Vaccinex Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Vaccinex balance sheet Accounts

Also Currently Popular

Additional Tools for Vaccinex Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Short Long Term Debt	+ 1.0	Short Long Term Debt Total
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 0.98	Total Assets
Other Stockholder Equity	+ 0.97	Net Tangible Assets
Other Stockholder Equity	+ 0.96	Capital Surpluse
Capital Surpluse	+ 0.94	Net Tangible Assets

Long Term Debt Total	- 0.99	Other Liab
Other Stockholder Equity	- 0.94	Retained Earnings
Retained Earnings	- 0.92	Net Tangible Assets
Other Stockholder Equity	- 0.91	Non Current Assets Total
Other Stockholder Equity	- 0.91	Property Plant And Equipment Net
Other Stockholder Equity	- 0.87	Non Currrent Assets Other